Iron, anaemia, and inflammatory bowel diseases
Top Cited Papers
Open Access
- 1 August 2004
- Vol. 53 (8), 1190-1197
- https://doi.org/10.1136/gut.2003.035758
Abstract
Iron deficiency anaemia is one of the most common disorders in the world. Also, one third of inflammatory bowel disease (IBD) patients suffer from recurrent anaemia. Anaemia has significant impact on the quality of life of affected patients. Chronic fatigue, a frequent IBD symptom itself, is commonly caused by anaemia and may debilitate patients as much as abdominal pain or diarrhoea. Common therapeutic targets are the mechanisms behind anaemia of chronic disease and iron deficiency. It is our experience that virtually all patients with IBD associated anaemia can be successfully treated with a combination of iron sucrose and erythropoietin, which then may positively affect the misled immune response in IBD.Keywords
This publication has 104 references indexed in Scilit:
- Regulation of Reticuloendothelial Iron Transporter MTP1 (Slc11a3) by InflammationJournal of Biological Chemistry, 2002
- Erythropoiesis and ironBest Practice & Research Clinical Haematology, 2002
- A randomized trial of iron deficiency testing strategies in hemodialysis patients11See Editorial by Besarab, p. 2412.Kidney International, 2001
- Sodium ferric gluconate complex in the treatment ofiron deficiency for patients on dialysisAmerican Journal of Kidney Diseases, 2001
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- Anemia in Crohn's diseaseDigestive Diseases and Sciences, 1994
- Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicityDigestive Diseases and Sciences, 1994
- Antilymphocyte globulin for mesalazine-associated aplastic anaemiaThe Lancet, 1994
- Iron Absorption and Serum Ferritin in Chronic Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1978
- The diagnosis of iron deficiency in patients with Crohn's diseaseGut, 1973